22939 results for "ega"
in 21.84 milliseconds.
-
Targeted Sequencing of Shwachman-Diamond syndrome bone marrow samples
Study EGAS00001004879 -
The Xq22.3 contiguous gene deletion syndrome (ATS-ID)
Study EGAS00001005354 -
Multifocal ileal NETs study WGS normal tissue
Study EGAS00001005620 -
APOBEC mutagenesis in EGFR mutant TKI resistance NSCLCs
Study EGAS00001005526 -
Exome sequencing in CLL re-treated with venetoclax
Study EGAS00001006158 -
Evolutionary histories of breast cancer and related clones
Study EGAS00001006282 -
Whole exome and genome sequencing investigations of perinatal death
Study EGAS00001006295 -
microRNA and isomiR profiling of Stage 1 epithelial ovarian carcinoma
Study EGAS00001006617 -
Frequencies of variants in the Danish population
Study EGAS00001006786 -
Genomic Analysis of a Metastatic Fusion-negative Embryonal Rhabdomyosarcoma
Study EGAS00001006946 -
RNA-seq of PDAC patient-derived xenograft tumors
Study EGAS00001007070 -
Detection of somatic mutations of angioimmunoblastic T-cell lymphoma
Study EGAS00001007333 -
Total_proteome
Dataset EGAD00010002549 -
Lyon University Hospital Molecular Endocrinology Laboratory Data Access Committee
Dac EGAC00001003363 -
The Extracellular RNA Quality Control (exRNAQC) study (phase 2)
Study EGAS00001006499 -
The Extracellular RNA Quality Control (exRNAQC) study (phase 1)
Study EGAS00001005263 -
Mesenchymal niche in myelodysplastic hematopoiesis at single cell resolution
Study EGAS00001007568 -
DAC-Clinical Outcomes of Diffuse Large B-Cell Lymphoma patients
Dac EGAC50000000595 -
NK cells in chronic viral hepatitis Data Access Committee
Dac EGAC50000000530 -
Data access committee for sequencing data generated by Wyatt Lab
Dac EGAC50000000538 -
University of Melbourne Centre for Cancer Research (UMCCR) Data Access Committee
Dac EGAC00001003567 -
Gene expression profile of mesothelial cells from peritoneal adhesion biopsies
Study EGAS00001005749 -
Genome-wide gene expression analysis following CRISPRi of transposable elements
Dac EGAC00001003585 -
MD Anderson Data Access Committee: Pembrolizumab in Advanced Rare Cancers
Dac EGAC50000000860
